XNAS
AMTX
Market cap112mUSD
Jul 10, Last price
1.60USD
1D
-4.55%
1Q
-25.99%
Jan 2017
20.86%
IPO
-70.63%
Name
Aemetis Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aemetis, Inc. is an enterprise specializing in renewable natural gas and sustainable fuels, conducting operations across North America and India. The company's business activities are structured into three primary divisions: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. A core objective for Aemetis is the procurement, development, and market launch of innovative products and technologies that offer negative carbon intensity, serving as eco-friendly alternatives to traditional petroleum-based goods. Its biodiesel products are distributed to a diverse range of customers, including government oil marketing agencies, transportation companies, various resellers, distributors, and private refiners. These sales are facilitated through both its in-house sales team and independent sales agents, as well as via brokers who then supply end-users. Beyond biodiesel, the company also produces and markets ethanol. Furthermore, Aemetis creates and supplies valuable co-products for animal feed, such as wet distillers grains, distillers corn oil, and condensed distillers solubles, to dairies and feedlots. The company's offerings also encompass the generation of dairy biogas, the production and sale of high-grade alcohol, various feed products, and hand sanitizers. Aemetis actively invests in research and development, particularly focusing on advanced conversion technologies that transform waste feedstocks into biofuels and biochemicals. Founded in 2005, the company initially operated as AE Biofuels, Inc. before officially adopting the name Aemetis, Inc. in November 2011. Its corporate headquarters are located in Cupertino, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||